CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 116 enrolled
Drug / intervention
FSME-Immune vaccinationbiological
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02511587
NCT02511587Phase 4Completed
CompareCT.gov

Comparison of Vaccination Routes: Subcutaneous Versus Intramuscular Application of FSME-Immun®

Medical University of Vienna·interventional·Posted Jul 30, 2015·Updated May 18, 2018

In Brief

A Phase 4 clinical trial evaluating FSME-Immune vaccination for Vaccine Efficacy. Completed, enrolled 116 participants.

Detailed Summary

FSME-Immun® is registered for application into the muscle. This study investigates if application under the skin leads to a comparable immune response.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsVaccine Efficacy
Countries--
Collaborators--

Timeline

Phase 4CompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedJul 30, 2015
Enrollment StartOct 1, 2012
Primary CompletionJun 1, 2015
TodayJul 2, 2026
Enrollment to primary: 2.7 yearsPosted 10.9 years ago

Interventions

FSME-Immune vaccinationbiological

booster vaccination with FSME-Immune